HIV/AIDS Immune Control
Interaction between Leishmania and HIV clarified
Published in AIDS Weekly, April 12th, 2004
"Parasitic infections such as leishmaniasis can modulate the life cycle of HIV-1 and disease progression," immunologists in Canada explained. "Coinfection with HIV-1 and Leishmania has emerged as a serious threat in countries where both pathogenic agents are widespread."
"Although there are numerous clinical reports illustrating the cofactor role played by Leishmania in HIV-1-infected patients, there is still no information on the contribution of Leishmania to the biology of HIV-1 in human lymphoid tissue that is considered a major in vivo site of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-04-12)
More Articles from AIDS Weekly
- Drug Development
Novel HIV fusion inhibitor T-1249 safe, effective in early trials - HIV/AIDS Therapy
HIV-infected cells have heightened vulnerability to electrical damage - HIV/AIDS Dyslipidemia
Bone mineral loss frequent in female patients during HAART - HIV/AIDS Neuropathology
Murine spatial learning and long-term potentiation disrupted by HIV Tat - HIV/AIDS Pathogenesis
Thiol/disulfide exchange needed for R4 HIV T-cell fusion during viral entry - Kaposi Sarcoma
Novel immunoassay distinguishes KS from mimics - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
